News | Cath Lab | July 07, 2017

Patient Race, Gender Both Important in Predicting Heart Attack Symptoms in the ER

A study looking at thousands of patients who came to the emergency department with chest pain found that different symptoms matter more and less in black and white men and women when it comes to predicting heart attacks

Patient Race, Gender Both Important in Predicting Heart Attack Symptoms in the ER

July 7, 2017 — Researchers at the George Washington University (GW) found that certain symptoms are more and less predictive of patients’ risk for acute coronary syndrome (ACS), which includes heart attack, in patients of different gender and race.

“When people come to the emergency department with chest pain or shortness of breath, emergency physicians must diagnose the cause. Classic symptoms of heart attack include pain in the center of the chest, shortness of breath, sweatiness and pain that goes down the left arm. Prior research showed that females, older adults and people with conditions such as diabetes do not show these classic symptoms,” said Jesse Pines, M.D., senior author and director of the Center for Healthcare Innovation and Policy Research at the GW School of Medicine and Health Sciences. “We wanted to know how different combinations of race and gender play into this.  Our overall goal was to better pinpoint what predicts these non-classic presentations of ACS.”

Pines and his research team found that while these classic symptoms, such as chest pain, can be helpful in determining which symptoms represent a heart attack, symptoms are differently predictive in varying genders and races. For example, white males and black females present with more classic symptoms of heart attack. By contrast, the only predictive symptom in black males was sweatiness. For white women, symptoms were not helpful at all.

The study, published in the Emergency Medicine Journal, looked at 4,162 emergency department patients with chest pain enrolled between 1999 and 2008. The GW research team looked at the association between 24 chest pain symptoms and 30-day ACS, and adjusted for age and cardiovascular comorbidities. In black males, only diaphoresis — excessive, abnormal sweating — was associated with ACS, while in white males, left arm pain, pressure/tightness and pain just below the sternal bone were associated with ACS. In black females, diaphoresis, as well as palpitations and left arm pain were associated with ACS, while chest pain and left anterior chest pain lowered ACS risk. No symptoms predicted ACS in white females.

Chest pain is the second most common presenting complaint in U.S. emergency departments, accounting for 7 million visits each year. Missing diagnosis of heart attack is the top reason emergency medicine physicians are named in malpractice cases. This study will give physicians better guidance on understanding which symptoms matter more for which groups to better distinguish patients with serious emergencies.

“All four subgroups, white males, black males, white females and black females, all present with heart attack differently,” said Ahmed Allabban, M.D., first author and emergency medicine resident at the GW School of Medicine and Health Sciences. “It is important for emergency medicine physicians to know that symptoms matter less for white women and black men and are more important for white men and black women. We hope this will also help patients to know whether the symptoms they are having should be more or less worrisome.”

Read the article “Race, Gender and Socioeconomic Factors Impact PCI Outcomes.”

Read the article “Greater Emphasis Needed on Preventing, Treating Heart Disease in Women.”

For more information: www.emj.bmj.com


Related Content

News | Cath Lab

March 25, 2026 — Royal Philips has launched its intuitive interventional guidance platform, IntraSight Plus, which is ...

Home March 26, 2026
Home
Feature | Cath Lab | Kyle Hardner

Since receiving FDA approval in 2016, intravascular lithotripsy (IVL) systems have grown in popularity among ...

Home November 14, 2025
Home
News | Cath Lab

Nov. 11, 2025 — FastWave Medical has successfully completed enrollment in its 30-patient coronary feasibility study and ...

Home November 13, 2025
Home
News | Cath Lab

Oct. 28, 2025 — Results from the first-of-its-kind randomized PROCTOR trial found that a strategy of saphenous vein ...

Home November 04, 2025
Home
News | Cath Lab

Oct. 27, 2025 — Results from the PREVUE-VALVE study suggest that there are currently at least 4.7 million people aged 65 ...

Home October 29, 2025
Home
News | Cath Lab

Oct. 25, 2025 — Medtronic plc has announced the launch of the Stedi Extra Support guidewire, designed to enhance ...

Home October 28, 2025
Home
News | Cath Lab

Oct. 27, 2025 — Elixir Medical, a developer of technologies to treat cardiovascular disease, has announced new clinical ...

Home October 28, 2025
Home
News | Cath Lab

Oct. 22, 2025 — Heartflow, Inc. has introduced Heartflow PCI Navigator, the newest addition to the Heartflow One ...

Home October 23, 2025
Home
News | Cath Lab

Oct. 15, 2025 — Stereotaxis recently announced it has obtained CE Mark in Europe and submitted a 510(k) application to ...

Home October 16, 2025
Home
News | Cath Lab

Oct. 7, 2025 — Medtronic has announced the full distribution of the Neuroguard IEP System (Neuroguard) after a ...

Home October 07, 2025
Home
Subscribe Now